Toni Rinow

Toni Rinow currently works at Converge Technology Solutions Corp., as Independent Director from 2022 and Sprout AI, Inc., as Independent Director from 2022.
Dr. Rinow also formerly worked at BetterLife Pharma, Inc., as Chief Executive Officer from 2019 to 2020, Smithkline Beecham Plc, as Medical Representative, ConjuChem, Inc., as Senior Analyst-Business Development from 1999 to 2000, Neptune Wellness Solutions, Inc., as Head-Investor Relations & Corporate Development, Neptune Wellness Solutions, Inc., as Chief Global Operating Officer, CFO & Secretary from 2020 to 2021, Mirati Therapeutics, Inc., as Vice President-Corporate Development from 2001 to 2004, Fonds de Solidarité FTQ, as Senior Vice President from 2004 to 2008, Jubilant DraxImage, Inc., as General Manager from 2018 to 2019, Isologic Innovative Radiopharmaceuticals Ltd., as Chief Operating Officer, and SANUWAVE Health, Inc., as Chief Financial Officer from 2022 to 2024.
Dr. Rinow received her graduate degree and Masters Business Admin degree from McGill University, doctorate degree in 1996 from the University of Montréal, and undergraduate degree from the University of Strasbourg.